Psychiatry and Behavioral Sciences
Showing 701-800 of 1,195 Results
-
M Windy McNerney, PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. M. Windy McNerney is the Director of Biological Sciences for the MIRECC at the Department of Veterans Affairs in Palo Alto, and a Clinical Associate Professor (Affiliated) at Psychiatry and Behavioral Sciences at Stanford School of Medicine. Dr. McNerney holds a particular passion for not only understanding the neurophysiology and biochemistry of mental health diseases, but also advocating for these invisible diseases. Her research focuses on neurodegeneration, depression, TBI, PTSD, and addiction. She is collaborating with researchers to integrate brain imaging and biochemical markers in hopes to better understand these diseases. She also is taking a lead role at the VA in investigating the biochemistry of magnetic brain stimulation and is the leader of the NeuroNado Laboratory. At Stanford University, she is the professor of two popular courses examining the biological and societal issues surrounding substance use disorder, with a major focus on opioids such as fentanyl. She has individually mentored over 25 students from underrepresented groups in STEM activities and leads monthly seminars aimed at facilitating career development. In her free time, she is a community advocate for the treatment of mental health and educates groups about the dangers of fentanyl.
She earned her BS from UC Davis and her PhD from the University of Notre Dame. While at ND, she interned at NASA Ames on Human Factors Engineering. She then went on to a postdoctoral position at Lawrence Livermore National Laboratory (DOE), and then completed a fellowship at the WRIISC program at the VA and Stanford University.
Selected Publications:
McNerney MW, Gurkoff G, Berryhill M (2023). The rehabilitation potential of neurostimulation for mild traumatic brain injury in animal and human studies. Brain Sciences, 13, 1402.
McNerney MW, Kraybill EP Narayanan S, Mojabi F, Venkataramanan V, Heath A (2023). Memory-related hippocampal brain-derived neurotrophic factor activation pathways from repetitive transcranial magnetic stimulation in the 3xTg-AD mouse line. Experimental Gerontology, 183, 11323.
Shuken, S, McNerney MW (2023). Cost and benefits for popular p-value correction methods I three models of quantitative omic experiments. Analytical Chemistry, 95, 2732.
McNerney MW, Heath A, Narayanan S, Yesavage J (2022). Repetitive transcranial magnetic stimulation improves brain-derived neurotrophic factor and cholinergic signaling in the 3xTgAD mouse model of Alzheimer’s disease. Journal of Alzheimer’s Disease, 86, 499..
Heath AM, Brewer M, Yesavage J, McNerney MW. (2021). Improved object recognition memory using post-encoding repetitive transcranial magnetic stimulation. Brain Stimulation, 15, 78.
Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, Toland A, Calcuttawala K, Shin H, Palovics R, Shin A, Wang EY, Luo J, Gate D, Schultz-Schaeffer WJ, Chu P, Siegenthalar J, McNerney MW, Keller A, Wyss-Coray T (2022). A human brain vascular atlas reveals diverse mediators or Alzheimer’s disease. Nature, 603, 885.
McNerney MW, Hobday T, Cole B, Ganong R, Winas N, Matthews D, Hood J, Lane S (2019). Objective classification of mTBI using machine learning on a combination of frontal electroencephalography measurements and self-reported symptoms. Sports Medicine Open, 4, 14.
McNerney MW, Sheng T, Nechvatal JM, Lee A, Lyons D, Adamson M (2018). Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volume and glucocorticoid receptor gene methylation. PLOSONE, e0192222.
Bennion BJ, Be NA, McNerney MW, Lao V, Carlson E, Valdez CA (2017). Predicting a drug’s membrane permeability: A computational model validated with in vitro permeability assay data. Journal of Physical Chemistry, B, 121, 5228.
See more publications at: https://www.ncbi.nlm.nih.gov/pubmed/?term=McNerney%20MW%5BAuthor%5D&cauthor=true&cauthor_uid=17107728 -
Zariah Mekile
Affiliate, Psychiatry and Behavioral Sciences
BioZariah J. Mekile, MS, MAP, is a doctoral candidate at the PGSP-Stanford Psy.D. Consortium, where she is pursing her PsyD in Clinical Psychology. She completed a BA in psychology with a minor in cognitive science and Spanish at Elizabethtown College, and a Master of Applied Psychology at Rutgers University-Graduate School of Applied and Professional Psychology.
-
Vinod Menon
Rachael L. and Walter F. Nichols, MD, Professor and Professor, by courtesy, of Education and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsEXPERIMENTAL, CLINICAL AND THEORETICAL SYSTEMS NEUROSCIENCE
Cognitive neuroscience; Systems neuroscience; Cognitive development; Psychiatric neuroscience; Functional brain imaging; Dynamical basis of brain function; Nonlinear dynamics of neural systems. -
Mitchell Miglis, MD
Clinical Associate Professor, Adult Neurology
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep MedicineCurrent Research and Scholarly InterestsProdromal markers of neurodegeneration in REM sleep behavior disorder
Autonomic dysfunction in Long-COVID
Postural tachycardia syndrome -
Emmanuel Mignot, MD, PhD
Craig Reynolds Professor of Sleep Medicine and Professor, by courtesy, of Genetics and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsThe research focus of the laboratory is the study of sleep and sleep disorders such as narcolepsy and Kleine Levin syndrome. We also study the neurobiological and genetic basis of the EEG and develop new tools to study sleep using nocturnal polysomnography. Approaches mostly involve human genetic studies (GWAS, sequencing), EEG signal analysis (deep learning), and immunology (narcolepsy is an autoimmune disease of the brain). We also work on autoimmune encephalitis.
-
Percy Khushroo Mistry
5717, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordResearch Scholar, Stanford Cognitive and Systems Neuroscience Laboratory
-
Anish Mitra
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioAnish Mitra is a neuroscientist and psychiatrist interested in understanding how neural activity in large-scale networks causes mental illness.
-
Hylton Molzof, PhD, MPH
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Molzof is a Clinical Assistant Professor and Licensed Psychologist in the Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine. She specializes in the assessment and treatment of sleep disorders via behavioral sleep medicine interventions, including Cognitive Behavioral Therapy for Insomnia (CBT-I) and positive airway pressure (PAP) desensitization. She also utilizes evidence-based techniques to help patients better manage circadian rhythm disorders, such as delayed sleep-wake phase disorder and shift work sleep disorder. Inspired by her background in public health, she has a strong interest in quality improvement and program development projects aimed at enhancing the quality and accessibility of sleep and circadian medicine for the diverse patient population served by Stanford Sleep Medicine Center.
-
Michelle Monje
Milan Gambhir Professor of Pediatric Neuro-Oncology and Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.
-
Rudolf Moos
Professor of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsOur research group works primarily on psychiatric program evaluation and the quality of health care. The studies focus heavily on health care programs and the context, process, outcome, and cost of care.
-
Kelli Moran-Miller, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Kelli Moran-Miller joined Stanford in Psychiatry & Behavioral Sciences in 2015. She is a licensed psychologist specializing in athlete mental health and sport and performance psychology. She also is a Certified Mental Performance Consultant with the Association of Applied Sport Psychology and a member of the US Olympic Committee registry. In her current role with Stanford Athletics (DAPER), she provides clinical and performance psychology services for varsity student-athletes, coaches, staff, and varsity sport teams. Prior to Stanford, she was the Director of Counseling and Sport Psychology - Athletics at the University of Iowa.
-
Philippe Mourrain
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
BioExpertise: Neurobiology, Sleep sciences, Molecular Genetics, Developmental Biology, Gene Silencing/Epigenetics
Methodology: Synapse Imaging (Two photon microscopy, Array Tomography), Calcium Imaging (Light Sheet Microscopy/SPIM, Light Field Microscopy), Optogenetics, CLARITY, Tol2 transgenesis, TALENs, CRISPR/Cas9, Video tracking and behavior computation. -
Pavithra Mukunda
Clinical Rsch Mgr, Psych/Public Mental Health & Population Sciences
Current Role at StanfordClinical Research Manager
-
Elvis Raymond Mukwikwi, MD
Fellow in Psychiatry and Behavioral Sciences
BioDr. Elvis Raymond Mukwikwi is a geriatric psychiatry fellow at Stanford University. He completed his medical training at the University of Montreal, followed by a specialization in psychiatry at McGill University. In addition to his clinical training, Dr. Mukwikwi is actively involved in neuropsychiatry research and has published work focusing on frontotemporal dementia. Beyond his clinical work, he is dedicated to patient advocacy.
-
Martin Stefan Mumenthaler
Adjunct Professor, Psych/Public Mental Health & Population Sciences
BioMartin Mumenthaler has a PharmD and a PhD in psychopharmacology from the University of Bern, Switzerland. He holds an appointment as Adjunct Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has been conducting research programs in addiction medicine and psychopharmacology, and teaching and mentoring medical students and residents on a voluntary basis.
Dr. Mumenthaler has also been working in various full-time positions in the pharmaceutical industry as Director in Clinical Development as well as in Medical Affairs, and as a consultant for early-stage pharma- and biotech companies providing advice on designing and conducting clinical trials, and analyzing and interpreting study results, mainly in the field of addiction medicine and pain.
His academic research has focused on the effects of psychoactive drugs on human performance, Aerospace Medicine, Alzheimer’s disease, and addiction medicine, and in these areas he has presented his results internationally and published over twenty-five peer-reviewed scientific articles. He has also served as a reviewer for various scientific journals, and is a member of the Research Society on Alcoholism, and an Associate Fellow of the Aerospace Medical Association. -
Greer Murphy M.D., Ph.D.
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult), Emeritus
Current Research and Scholarly InterestsPharmacogenetics of mood disorders and nicotine addiction. Microglial neurotoxicity and neuroprotection in Alzheimer's disease. Genome wide expression analysis of mouse models for Alzheimer's disease.
-
Diana Naranjo
Clinical Professor, Pediatrics - Endocrinology
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child DevelopmentBioAs a licensed clinical psychologist working in diabetes and Cystic Fibrosis clinics for the past 10 years, Dr. Naranjo focuses on the psychosocial needs of patients and families with diabetes and CF. Through clinical research, she aims to understand barriers and facilitators to diabetes self-management, how families and individuals with diabetes respond to health technology, and how to best provide services that engage youth and their families. She is a member of the Stanford Diabetes Research Center.
-
Trishna Narula, MD, MPH
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Narula is currently serving patients at Stanford's centerspace clinic, where she is also working to lead and launch a new South Asian program.
-
Kalpana Isabel Nathan
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioKalpana Nathan, MD is an adjunct clinical professor, Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. After completion of residency and research fellowship at Stanford, she served 4 years at the San Francisco General Hospital/UCSF, gaining experience in the areas of substance use, HIV and public health. She worked at Palo Alto VA for more than a couple of decades. She served as chief medical director at Mental Health and Addiction services, El Camino Health for two and a half years, and later was the Executive Medical Director of Custody Behavioral Health at Santa Clara County. She is a certified physician executive. She has worked and taught in various settings, both inpatient and outpatient, as well as private and public sectors. She is board certified in General, Addiction and Forensic Psychiatry, as well as Lifestyle Medicine. Her interests include wellness and self-care for physicians, women's health, health creation and resiliency building for the community. She is a certified meditation teacher, has completed sprint and Olympic triathlons, and enjoys traveling around the world. She received the outstanding community clerkship preceptor award in 2010 and the Arthur L. Bloomfield Award in Recognition of Excellence in the Teaching of Clinical Medicine in 2015 at the Stanford University School of Medicine.
Recent Publications:
1. Yen Li, M, Mata C, Nathan K: Is Life Unlivable for Youth in Post-DEI America?: Understanding Rising Suicide Rates Across Diverse Youth Groups Through Traditional Suicide Paradigms. Healthcare 2025 Oct, 13(20), 2585 https://doi.org/10.3390/healthcare13202585
2. Tran BX, Nguyen TT, Boyer L, Fond G, Auquier P, Nguyen HSI,Ha Thi Nhi Tran HTN, Nguyen HM, Choi J, Le HT, Latkin CA, Nathan KI, Husain SF, et al: Differentiating people with schizophrenia from healthy controls in a developing country: An evaluation of portable functional near infrared spectroscopy (fNIRS) as an adjunct diagnostic tool. Frontiers of Psychiatry 2023 Jan 26; vol 14
3. Tatum, J, Nathan, K: The USA. Lancet Psychiatry 2021, 8(5):365-366
4. Nathan N & Nathan KI: Suicide, Stigma, and Utilizing Social Media Platforms to Gauge Public Perceptions. Front. Psychiatry 2020 January 13
5. Tran BX, Nathan KI, Phan HT, Hall BJ, Vu GT et al: A Global Bibliometric Analysis of Services for Children Affected by HIV/Acquired Immune Deficiency Syndrome: Implications for Impact Mitigation Programs (GAPRESEARCH). AIDS Rev. 2019 Oct 3;21(3).
6.Lee A, Nathan KI: Understanding Psychosis in a Veteran With a History of Combat and Multiple Sclerosis. Fed Pract. 2019 Jun;36(Suppl 4):S32-S35.
7. Tran BX, Ha GH, Vu GT, Nguyen LH, Latkin CA, Nathan K, McIntyre RS, Ho CS, Tam WW, Ho RC: Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis. Int J Environ Res Public Health. 2019 Jun 26;16(13) -
Shaghayegh Navabpour
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsMy research investigates how genetic, transcriptomic, and epigenomic mechanisms shape brain function and contribute to psychiatric disorders, with a special focus on PTSD. By combining large-scale human genomic data with molecular neuroscience approaches, I aim to identify cell-type-specific pathways and therapeutic targets that advance our understanding and treatment of mental health conditions.
-
Seigo Ninomiya
Clinical Research Coordinator Associate, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioAt Stanford University School of Medicine, Seigo worked in NIH funded Clinical trials for a variety of neuropsychiatric disorder, and hands-on experience dealing data from neuroimaging methods such as fMRI, EEG, and 3D Neuro-navigation system. At UCSF School of Medicine, he has completed the internship program with the Center for Intelligent Imaging. As a part of Biomagnetic Imaging Lab and Speech Neuroscience Lab at UCSF School of Medicine, He has done data processing, Data QC, and analysis of MEG, fMRI data and several neuropsych scales such as GAD7, YBOCS, and Tinnitus Functional Index. He have hands-on experience on advanced neuroimaging technologies including fMRI and EEG in laboratory settings at University of California Davis., and obtained a CITI training certificate in both biological/behavioral training, and MRI training certificate from UC Davis Imaging Research center.
-
Seiji Nishino
Professor (Research) of Psychiatry & Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsThe research focus of the Sleep and Circadian Neurobiology (SCN) Laboratory is the study of the sleep and circadian physiology using various animal models. A portion of the research is carried out using rodent models of narcolepsy and circadian rhythm sleep disorders. The laboratory also carries out pharmacological studies aiming to develop new treatments for these sleep disorders.
-
Douglas Noordsy
Clinical Professor, Psychiatry and Behavioral Sciences
BioDouglas L. Noordsy, MD, is Clinical Professor, Director of Lifestyle Psychiatry and co-founder of the Sports Psychology & Psychiatry clinic in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. Dr. Noordsy was previously Professor of Psychiatry at the Geisel School of Medicine at Dartmouth. His research interests include effects of physical exercise on neurotrophic factors, brain volume and function and mental health and wellbeing. He is particularly interested in the role of physical exercise for prevention of progression of early psychosis and interactions between social and physical aspects of team sports. Dr. Noordsy is a member of the American College of Psychiatry, American College of Lifestyle Medicine and is a Distinguished Fellow of the American Psychiatric Association. He is a member of the editorial boards for Community Mental Health Journal and Mental Health & Physical Activity. Dr. Noordsy was recognized with the Exemplary Psychiatrist Award from the National Alliance on Mental Illness in 2001, and the Excellence in Leadership Award from the Department of Psychiatry & Behavioral Sciences at Stanford in 2018. He launched the Stanford Lifestyle & Sports Psychiatry Special Initiative of the Department of Psychiatry in 2024 and is seeking philanthropic partners.
https://med.stanford.edu/psychiatry/special-initiatives/lifestyle.html
https://med.stanford.edu/psychiatry/patient_care/lifestyle.html -
Ruth O'Hara
Director, Spectrum, Senior Associate Dean, Research and Lowell W. and Josephine Q. Berry Professor
Current Research and Scholarly InterestsDr. O'Hara's research aims to investigate how cognitive information processing deficits subserve affective symptoms in psychiatric disorders, and interact with key brain networks integral to these disorders. To do so, she has implemented a translational, interdisciplinary program that encompasses cellular models, brain and behavioral assays of affective and cognitive information processing systems in psychiatric disorders across the lifespan.
-
Maurice M. Ohayon, MD, DSc, PhD
Professor of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsMain focus is epidemiology of sleep and psychiatric disorders in the general population and clinical settings: 1)sleep habits and patterns; 2) prevalence, diagnosis, co-morbidity, treatment and Public Health impact of sleep disorders; 3) pain, posttraumatic stress disorder, social phobia, panic disorder and generalized anxiety; 4) epidemiology of narcolepsy and hypersomnia.
-
Clayton Olash
Affiliate, Psychiatry and Behavioral Sciences
BioClayton Olash, MD is a psychiatry resident at the Medical University of South Carolina and an affiliate researcher with Stanford University. His work bridges psychiatry, neuroscience, and contemplative traditions, with a focus on how altered states of consciousness can catalyze lasting psychological change.
Clayton's current research spans multiple projects, including studies on ibogaine and its impact on the default mode network, rapid-acting neuromodulation techniques such as SAINT TMS combined with meditation, and a novel high-dose electrotherapy device for home-based treatment of depression. His broader aim is to understand how psychedelics, brain stimulation, and meditative practices can modulate self-related processing and promote enduring well-being.
With backgrounds in philosophy, psychology, and medicine, Clayton's work emphasizes integration: uniting ancient contemplative wisdom with modern neuroscience and emerging technologies. His long-term goal is to develop translational models of care that transform transient altered states into sustainable therapeutic traits. -
Alisa Marie Olmsted
Clinical Assistant Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
BioI am a board-certified psychiatrist specializing in interventional treatments for mood disorders, including transcranial magnetic stimulation (TMS), esketamine, and intravenous ketamine. I completed an Advanced MD Fellowship at the Sierra Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), a Veterans Affairs (VA) Center of Excellence at VA Palo Alto, where my work focused on circuit-based approaches to precision psychiatry. I completed residency at Jefferson University Hospital, where I served as research chief and served on the ethics board, gaining broad clinical experience across inpatient, emergency, consultation-liaison, and addiction psychiatry. My research on Veterans has been published in Nature Mental Health and the Journal of Affective Disorders Reports, while my earlier clinical work was cited in The New York Times. I have provided continuous care to Veterans since medical school, including at the Hunter Holmes VA, where I earned honors, and at the Wilmington VA community-based outpatient clinic (CBOC). My commitment to serving Veterans is informed by a family legacy that includes multiple generations of combat Veterans, a perspective that continues to shape my clinical and research priorities within the VA system.
-
Nichole Olson
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Nichole Olson is a Clinical Assistant Professor and licensed psychologist in the INSPIRE Clinic and Dialectical Behavior Therapy (DBT) program at Stanford. Dr. Olson completed her masters and doctorate degrees at Northwestern University in Chicago and finished her postdoctoral fellowship at Stanford University. Dr. Olson specializes in evidence-based, recovery-oriented care for individuals with psychosis, providing both individual and group Cognitive Behavioral Therapy for Psychosis (CBTp) to adults within the INSPIRE Clinic. In addition, Dr. Olson leads trainings and ongoing consultation for providers learning to implement CBTp. As a clinician and Assistant Director of Stanford’s DBT program, Dr. Olson also provides individual DBT treatment for those with emotion regulation difficulties.
-
Nnamdi Orakpo, MD, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Nnamdi Orakpo is a fellowship-trained sleep medicine specialist with Stanford Health Care. Dr. Orakpo is also a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences, Division of Sleep Medicine at Stanford University School of Medicine.
Dr. Orakpo specializes in sleep medicine and sleep psychiatry. He focuses on sleep-related conditions, including chronic insomnia, narcolepsy, sleep apnea, restless leg syndrome, and trauma-associated sleep disorders. Dr. Orakpo also treats patients with ADHD, depression, anxiety disorders, neurocognitive disorders, and post-traumatic stress disorder. He offers interventional psychiatry treatments, including ketamine therapy and transcranial magnetic stimulation.
Dr. Orakpo led a pioneering study on virtual reality neurofeedback to treat insomnia and chronic centralized pain. He has also studied managing sleep apnea and obesity using GLP-1 medications. His other research has looked at the development of a rare movement disorder (propriospinal myoclonus) after taking metoclopramide during pregnancy.
Dr. Orakpo has published his research in peer-reviewed journals, including Sleep, Frontiers in Human Neuroscience, and Frontiers in Psychiatry. He co-wrote a clinical sleep medicine textbook with his colleagues, contributing chapters on chronic insomnia, isolated sleep paralysis, sleep-related eating disorders, sexsomnia, and exploding head syndrome. Dr. Orakpo has presented to his peers at international and national meetings of the World Sleep Congress/World Dentofacial Sleep Society, the American Academy of Neurology, and the American Public Health Association.
Dr. Orakpo is a member of many professional organizations, including the American Academy of Sleep Medicine, the American Psychiatric Association, the North American Neuromodulation Society, and the World Sleep Society. -
Karen Osilla
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsDr. Osilla conducts health services research with a focus on supporting families impacted by substance use. Dr. Osilla has been conducting addictions research since 2006 and has been involved in clinical trials evaluating cognitive behavioral therapy, collaborative care, and motivational interviewing interventions (web and in-person) among youth, adult, military, family members, and other hard-to-reach populations.
-
Michael Ostacher
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Ostacher is Professor of Psychiatry and Behavioral Sciences. He is the Site Director for the Addiction Medicine Fellowship at the VA Palo Alto Health Care System, where he also serves as the Medical Director of the Pharmacology of Addiction Recovery Clinic, the Director of the Bipolar and Depression Research Program and the Co-Director of the VA/Stanford Exploratory Therapeutics Lab, the Director of Advanced Fellowship Training in Mental Illness Research and Treatment for MDs for the VISN 21 MIRECC, and the Site Director at the VA Palo Alto for Advanced Fellowship Training for Stanford. A graduate of Vanderbilt University School of Medicine, the Harvard School of Public Health, and Harvard Medical School, he completed his training at The Cambridge Health Alliance at Harvard Medical School in Adult Psychiatry, Public Psychiatry, and Geriatric Psychiatry, and is currently board certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine. He is the Digital Content Editor for the journal Evidence-Based Mental Health and is on the editorial boards of Bipolar Disorders, the International Journal of Bipolar Disorders, the Journal of Clinical Psychiatry, Current Psychiatry, and Psychiatric Annals. His current research includes roles as Site Investigator for VA-BRAVE, multicenter, randomized trial comparing long-acting injectable buprenorphine to sublingual buprenorphine/naloxone, and trials of psychedelic drugs in psychiatric disorders in Veterans. With funding from NIDA, he studied, along with Jaimee Heffner, Ph.D. at the Fred Hutchinson Cancer Research Center in Seattle, smoking cessation in people with bipolar disorder using a novel online psychotherapy derived from Acceptance and Commitment Therapy. His work using a Capnometry Guided Respiratory Intervention (CGRI) for PTSD led to the FDA clearance for Freespira, a digital therapeutic, for the treatment of PTSD. His primary research interest is in large clinical trials mental health and addiction, and the implementation of evidence-based mental health practices.
-
Heather Ryan Pankow
Life Science Rsch Prof 2, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordLife Science Research Professional 2 in The Depression Research Clinic
-
Sara Pardej
Postdoctoral Scholar, Psychiatry
BioSara Pardej earned her BA in Psychology and BS in Cognitive Science at Marquette University. Afterwards, she attended the Clinical Psychology Doctoral Program at the University of Wisconsin-Milwaukee under the mentorship of Dr. Bonita P. Klein-Tasman, where she earned both her MS and PhD in Clinical Psychology. There, she worked on several studies focusing on youth with neurofibromatosis type 1 (NF1), including behavioral phenotyping work, psychometric studies, and a social skills intervention study. Her dissertation study, which was funded by a Young Investigator Award from the Children's Tumor Foundation, focused on examining event related potentials using EEG by comparing children with NF1 to children with idiopathic ADHD and unaffected children. She completed her Doctoral Internship in Clinical Psychology at Penn State Health in Hershey, Pennsylvania. While at Penn State, she also worked on research examining safety and psychopathology in youth with ADHD and/or autism. Her clinical interest is neuropsychology, and her research interests include issues of psychometrics, behavioral phenotyping, and the neuropsychological development (and subsequent areas of intervention) of individuals with NF1 across the lifespan.
